(Q40023848)

English

SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model

scientific article published on 17 January 2008

In more languages
default for all languages
No label defined

No description defined

Statements

SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model (English)
Michael J Corbley
Jessica E Friedman
James L Papadatos
Frank Lutterodt
P Ann Boriack-Sjodin
Robert M Arduini
Jonathan N Mead
Claudio E Chuaqui
Mark Cornebise
Mary Beth Carter
Juswinder Singh
Wen-Cherng Lee

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit